NASH: From liver diseases to metabolic disorders and back to clinical hepatology

Hepatology

Volumn 35, Issue 2, 2002, Pages 497-499

  Marchesini, Giulio ^a   Forlani, Gabriele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CHRONIC LIVER DISEASE; DISEASE MODEL; EDITORIAL; FATTY LIVER; GENOTYPE; HEMOCHROMATOSIS; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER NECROSIS; LIVER TRANSPLANTATION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY CHAIN; UNITED STATES;

EID: 0036154816     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.31551     Document Type: Article

References (29)

1. Nonalcoholic steatohepatitis: Mayo Clinic experience with an hitherto unnamed disease
2. Liver steatosis and liver resection
3. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
4. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
5. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the U.S.
6. The worldwide obesity epidemic
7. Cause-specific mortality in type 2 diabetes. The Verona diabetes study
8. Liver fibrosis in overweight patients
9. Liver pathology and the metabolic syndrome X in severe obesity
10. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
11. NASH and insulin resistance: Insulin secretion and specific association with the insulin resistance syndrome
12. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
13. Nonalcoholic steatohepatitis, insulin resistance and metabolic syndrome: Further evidence for an etiological association
14. Comment on the provisional report from the WHO consultation
15. Insulin resistance in non-alcoholic steatohepatitis
16. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
17. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome
18. Association of nonalcoholic fatty liver disease with insulin resistance
19. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis
20. Metformin in non-alcoholic steatohepatitis
21. Mitochondrial abnormalities in nonalcoholic steatohepatitis
22. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
23. Does nonalcoholic steatohepatitis progress to cryptogenic cirrhosis and hepatocellular carcinoma? A case-control study
24. Prevalence of obesity and diabetes in patients with hepatocellular carcinoma developed in cryptogenetic underlying liver disease
25. Hepatocellular carcinoma, liver failure and liver mortality in obesity-related cryptogenic cirrhosis
26. Relative risk of hepatocellular carcinoma in cirrhosis due to fatty liver disease: A study based on incidental hepatocellular carcinoma in liver transplant recipient
27. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Natural history?
28. Hepatocellular carcinoma arising in nonalcoholic steatohepatitis
29. Hepatic hyperplasia in noncirrhotic fatty livers: Is obesity-related hepatic steatosis a premalignant condition?